Browse Category

NASDAQ:IRTC News 9 January 2026 - 13 January 2026

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land

New York, Jan 13, 2026, 14:56 (EST) — Regular session Shares of iRhythm Technologies (IRTC) fell 7.5% to $156.24 in Tuesday afternoon trading, following the company’s release of its 2026 sales and profitability goals alongside a plan for corporate restructuring. The timing is key. The update landed right in the middle of the J.P. Morgan Healthcare Conference in San Francisco, a week when medtech and biotech firms typically shape the year’s initial outlook. iRhythm is working hard to reassure investors it can sustain growth as it pushes toward profitability. The company hasn’t published its full 2025 results yet, leaving the
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue

New York, January 12, 2026, 16:13 EST — After-hours Shares of iRhythm Technologies Inc (IRTC.O) fell 5.6% to $169.30 in late Monday trading following a preliminary business update at the J.P. Morgan Healthcare Conference. The stock fluctuated between $157.34 and $179.82, with roughly 1.35 million shares changing hands. Timing is crucial. JPM week typically pushes companies to reveal their cards sooner, and the market has little patience for results that come off as just “fine” after a solid rally. iRhythm now expects 2025 revenue to top the high end of its previous guidance of $740 million, driven by record unit
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference

New York, Jan 9, 2026, 15:54 EST — Regular session Shares of iRhythm Technologies (IRTC.O) fell 3.9% to $181.95 on Friday, after swinging between $190.16 and $179.61 in the session. The stock ended Thursday at $189.25. The drop left iRhythm behind a broader advance in U.S. equities, with S&P 500 and Nasdaq-tracking funds up about 0.8% and 1.1%, respectively. That gap matters because iRhythm trades like a growth stock — sensitive to rate moves and risk appetite — and those currents can swamp stock-specific news for stretches. A Labor Department report showed nonfarm payrolls — a broad count of jobs

Stock Market Today

SGX share price dips at week’s end after record profit; what investors watch next

SGX share price dips at week’s end after record profit; what investors watch next

7 February 2026
Singapore Exchange shares closed 0.4% lower at S$17.57 on Friday, despite reporting record half-year results and a higher dividend earlier in the week. Broker targets diverged after the update, with Maybank and DBS raising targets while Citi stayed bearish. Investors are watching for signs of momentum from derivatives and equity-market reforms as the next session opens Monday.
South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Go toTop